BioAtla News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

23.09.24	BioAtla Grants Exclusive, Worldwide License To Context Therapeutics To Develop BA3362 (RTTNews)
26.08.24	Blick ins Portfolio: In diese Aktien hat Big Short-Investor Michael Burry in Q2 2024 investiert (finanzen.ch) Auch in diesem Quartal lässt der Big Short-Investor Michael Burry entsprechend der SEC-Vorschriften einen Einblick in sein Portfolio gewähren.» mehr
23.07.24	BioAtla Says Its Drug Ozuriftamab Vedotin To Treat SCCHN Got Fast Track Designation (RTTNews)
06.05.24	BioAtla Says FDA Clears IND Application For BA3361 For The Treatment Of Multiple Tumors (RTTNews)
29.12.22	Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors (PR Newswire)
04.11.22	PRVB Awaits FDA's Decision, BCAB Soars On Clinical Trial Updates, CYTK Braces For Busy Months (RTTNews)
12.09.22	Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011) (PR Newswire)
05.05.22	ABC Boosts EPS Outlook, ADPT Sees 20-26% Revenue Growth, ANAB To Report HARP Data In Q3 (RTTNews)
01.03.22	BIOATLA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS (PR Newswire)
10.01.22	BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin (BA3011) and Ozuriftamab Vedotin (BA3021) in Combination with Opdivo® (nivolumab) for Treatment of So... (PR Newswire)
21.12.21	BIOATLA APPOINTS EDWARD L. WILLIAMS TO BOARD OF DIRECTORS (PR Newswire)
15.11.21	BioAtla Announces Third Quarter 2021 Financial Results And Provides Clinical And Business Update (PR Newswire)
29.09.21	BioAtla Announces Private Placement of 2.7 Million Shares (PR Newswire)
13.08.21	BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical Update (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’265.00	3.01 %	K V
Sonova Hldg	311.50	2.47 %	K V
Novartis	93.81	2.46 %	K V
Geberit	524.80	1.59 %	K V
ABB	50.28	1.41 %	K V
UBS Group	28.32	0.64 %	K V
Kuehne+Nagel Int	209.30	0.63 %	K V
Givaudan	3’935.00	0.41 %	K V
Nestle	76.22	0.34 %	K V
Lonza Grp	523.00	0.27 %	K V